Business ❯ Healthcare ❯ Pharmaceuticals

Vaccine Development

Moderna Moderna Inc. Public Health Policy Patent Rights Funding Strategies Pricing Strategies Respiratory Vaccines mRNA Technology Acquisitions Next-Generation Medications Public Health Bavarian Nordic Vaccines Acquisition Gardasil Clinical Trials Norovirus Vaccine

Sanofi to Buy Dynavax for $2.2 Billion in All-Cash Tender Offer

The cash offer seeks to expand Sanofi’s adult immunization portfolio via a two-dose hepatitis B vaccine alongside an early shingles candidate.

Moderna Trims 2025 Forecast as Q3 Loss Narrows and Revenue Beats

Moderna Cuts 10% of Global Workforce in Major Cost Overhaul

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform